ABMD Financial Facts
Provision for income taxes: 5.86MFunded research and development: 27K
See Full Income Statement
Total current assets: 319.87M
Treasury stock at cost - 50,954 shares: -46.27M
See Full Balance Sheet
Abiomed Inc. (ABMD) Earnings
|
Expand Research on ABMD
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +11.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/2/23 | Q323 | N/A | $1.18 | N/A | N/A | $290.55M | = | N/A | N/A | ||
| 11/1/22 | Q223 | $1.03 | $1.00 | +$0.03 | $248.14M | $272.69M | = |  | | Details | |
| 8/4/22 | Q123 | $1.25 | $1.06 | +$0.19 | $277M | $278.98M | = | | | Details | |
| 4/28/22 |  |
Q422 | $1.16 | $1.09 | +$0.07 | $270M | $267.67M | = | | | Details |
| 2/3/22 | |
Q322 | $1.13 | $0.97 | +$0.16 | $261M | $253.8M |  |
| | Details |
| 10/28/21 | |
Q222 | $1.03 | $0.97 | +$0.06 | $248.1M | $247.66M | |
| | Details |
8/5/21  |
|
Q122 | N/A | $1.05 | N/A | N/A | $240.91M | |
N/A | N/A | |
| 4/29/21 | |
Q421 | $1.11 | $1.10 | +$0.01 | $241M | $230.38M | |
| | Details |
